Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rongjian Juanbi Granules
- Development stage
- Unknown
- Lead developer
- Gansu Provincial Hospital of Traditional Chinese Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Rongjian Juanbi Granules is a Traditional Chinese Medicine (TCM) formulation developed by the Gansu Provincial Hospital of Traditional Chinese Medicine. It is primarily indicated for the treatment of knee osteoarthritis and degenerative bone and joint diseases. As a TCM granule, it is designed to alleviate symptoms associated with "Bi" syndrome, which in Chinese medicine refers to pain, stiffness, and obstruction in the joints and musculoskeletal system. In clinical trial settings, such as the interventional study ChiCTR2100051020, it has been evaluated for its efficacy and safety in comparison to standard analgesic treatments like paracetamol. The formulation typically consists of a proprietary blend of herbal extracts processed into a granule form for oral administration.
- Brand names
- Rongjian Juanbi Granules
- Other names
- Rongjian Juanbi Granules
02
Targets
NF-κBFGFR1 (Fibroblast growth factor receptor 1)FOS (Activator Protein 1)
Beyond the preview
Go deeper on Rongjian Juanbi Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rongjian Juanbi Granules.